Article
KRAS Mutant Status, p16 and β-catenin Expression May Predict Local Recurrence in Patients Who Underwent Transanal Endoscopic Microsurgery (TEMS) for Stage I Rectal Cancer.
Anticancer research - 1 Oct 2016
Sideris Michail, Moorhead Jane, Diaz-Cano Salvador, Bjarnason Ingvar, Haji Amyn, Papagrigoriadis Savvas
Abstract excerpt
BACKGROUND/AIM: Transanal endoscopic microsurgery (TEMS) is emerging as an alternative treatment for rectal cancer Stage I. There remains a risk of local recurrence. The Aim of the study was to study the effect of biomarkers in local recurrence for Stage I rectal cancer following TEMS plus or minus radiotherapy. MATERIALS AND METHODS: This is a case control study where we compared 10 early rectal cancers that had...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.